These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8587416)

  • 1. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044.
    Kojima M; Kusumoto K; Fujiwara S; Watanabe T; Fujino M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S365-8. PubMed ID: 8587416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
    Watanabe T; Awane Y; Ikeda S; Fujiwara S; Kubo K; Kikuchi T; Kusumoto K; Wakimasu M; Fujino M
    Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
    McMurdo L; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
    Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
    Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat.
    Lee JY; Warner RB; Adler AL; Opgenorth TJ
    Pharmacology; 1994 Nov; 49(5):319-24. PubMed ID: 7862744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
    Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion.
    Burke SE; Nelson RA
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):87-92. PubMed ID: 9007676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonselective endothelin receptor antagonist initiated soon after the onset of myocardial infarction may deteriorate 24-hour survival.
    Takahashi C; Kagaya Y; Namiuchi S; Takeda M; Fukuchi M; Otani H; Ninomiya M; Yamane Y; Kohzuki M; Watanabe J; Shirato K
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):29-38. PubMed ID: 11444500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new endothelin receptor antagonist, TAK-044, on myocardial stunning in dogs.
    Kitayoshi T; Ikeda S; Kubo K; Awane-Igata Y; Watanabe T; Fujino M
    Eur J Pharmacol; 1996 Jun; 305(1-3):137-43. PubMed ID: 8813544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion.
    Grover GJ; Dzwonczyk S; Parham CS
    Cardiovasc Res; 1993 Sep; 27(9):1613-8. PubMed ID: 8287438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATP-dependent potassium channel: an endogenous cardioprotective mechanism.
    Yao Z; Gross GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S28-34. PubMed ID: 7898105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog.
    Krause SM; Lynch JJ; Stabilito II; Woltmann RF
    Cardiovasc Res; 1994 Nov; 28(11):1672-8. PubMed ID: 7842461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion.
    Alberola Aguilar AM; Revert F; Moya A; Beltrán J; García J; San Martín E; Sancho S; Such L
    Gen Pharmacol; 2000 Sep; 35(3):143-7. PubMed ID: 11744236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation.
    Baxter GF; Yellon DM
    J Mol Cell Cardiol; 1999 May; 31(5):981-9. PubMed ID: 10336838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of 17 beta-estradiol produced by activation ofmitochondrial ATP-sensitive K(+)Channels in canine hearts.
    Lee TM; Su SF; Tsai CC; Lee YT; Tsai CH
    J Mol Cell Cardiol; 2000 Jul; 32(7):1147-58. PubMed ID: 10860759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of an adenosine A1 analogue and ischemic preconditioning in isolated rabbit hearts.
    Lasley RD; Noble MA; Konyn PJ; Mentzer RM
    Ann Thorac Surg; 1995 Dec; 60(6):1698-703. PubMed ID: 8787466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
    Tsuchida A; Thompson R; Olsson RA; Downey JM
    J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.